Q4/2022: Monthly: Anatara Lifesciences (ANR: 3.40c) in bottom 4% performers of Australian market in past quarter

Medicine

Press/Media: Research

PeriodDec 30 2022

Media coverage

1

Media coverage

  • TitleQ4/2022: Monthly: Anatara Lifesciences (ANR: 3.40c) in bottom 4% performers of Australian market in past quarter
    Media name/outletAustralian Co News Bites Stock Report
    Country/TerritoryAustralia
    Date12/30/22
    PersonsMichael L. West
View all 1
View less